FR2092103B1 - - Google Patents
Info
- Publication number
- FR2092103B1 FR2092103B1 FR7114959A FR7114959A FR2092103B1 FR 2092103 B1 FR2092103 B1 FR 2092103B1 FR 7114959 A FR7114959 A FR 7114959A FR 7114959 A FR7114959 A FR 7114959A FR 2092103 B1 FR2092103 B1 FR 2092103B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3272370A | 1970-04-28 | 1970-04-28 | |
US11306771A | 1971-02-05 | 1971-02-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2092103A1 FR2092103A1 (en) | 1972-01-21 |
FR2092103B1 true FR2092103B1 (fr) | 1975-10-10 |
Family
ID=26708789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7114959A Granted FR2092103A1 (en) | 1970-04-28 | 1971-04-27 | Androgenic and anabolic 14-dehydro-19-nor test-osterones |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS535296B1 (fr) |
AR (1) | AR192710A1 (fr) |
BE (1) | BE766396A (fr) |
CA (1) | CA943126A (fr) |
CH (1) | CH567520A5 (fr) |
DE (1) | DE2119708C3 (fr) |
DK (1) | DK128209B (fr) |
ES (1) | ES390645A1 (fr) |
FR (1) | FR2092103A1 (fr) |
IL (1) | IL36628A (fr) |
NL (1) | NL7105798A (fr) |
SE (1) | SE379356B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030069215A1 (en) | 2001-03-30 | 2003-04-10 | The Government Of The United States Of America, | Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate |
DE60121928T2 (de) | 2000-03-31 | 2007-03-01 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Verfahren zur herstellung von den trans-4-n-butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)-dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3374228A (en) * | 1965-10-25 | 1968-03-19 | Syntex Corp | 14beta-estra-1, 3, 5(10)-trienes |
US3467682A (en) * | 1967-04-28 | 1969-09-16 | Searle & Co | 13beta-alkyl-17alpha-alkynylgon-4-ene-3beta,17beta-diols and esters corresponding |
-
1971
- 1971-04-14 IL IL36628A patent/IL36628A/xx unknown
- 1971-04-20 CA CA110,864A patent/CA943126A/en not_active Expired
- 1971-04-22 DE DE2119708A patent/DE2119708C3/de not_active Expired
- 1971-04-26 DK DK199371AA patent/DK128209B/da unknown
- 1971-04-26 CH CH609071A patent/CH567520A5/xx not_active IP Right Cessation
- 1971-04-27 FR FR7114959A patent/FR2092103A1/fr active Granted
- 1971-04-27 SE SE7105427A patent/SE379356B/xx unknown
- 1971-04-27 ES ES390645A patent/ES390645A1/es not_active Expired
- 1971-04-27 AR AR235240A patent/AR192710A1/es active
- 1971-04-28 JP JP2850271A patent/JPS535296B1/ja active Pending
- 1971-04-28 BE BE766396A patent/BE766396A/fr unknown
- 1971-04-28 NL NL7105798A patent/NL7105798A/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BE766396A (fr) | 1971-10-28 |
DE2119708A1 (de) | 1971-11-11 |
DE2119708C3 (de) | 1981-10-08 |
CH567520A5 (fr) | 1975-10-15 |
JPS535296B1 (fr) | 1978-02-25 |
FR2092103A1 (en) | 1972-01-21 |
SE379356B (fr) | 1975-10-06 |
IL36628A0 (en) | 1971-06-23 |
ES390645A1 (es) | 1974-04-01 |
DK128209B (da) | 1974-03-18 |
IL36628A (en) | 1978-08-31 |
NL7105798A (fr) | 1971-11-01 |
CA943126A (en) | 1974-03-05 |
DE2119708B2 (de) | 1980-07-17 |
AR192710A1 (es) | 1973-03-14 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |